FRI546 VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor In Development For Thyroid Eye Disease (TED): Pharmacodynamic Responses In Healthy Volunteers And Patients With Active...

por Foster, Kelly, Dickinson, Brent A, Summerfelt, Rochelle M, She, Angela, Bedian, Vahe, Katz, Barrett
Publicado 2023

FRI545 Durability Of Treatment Response With VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor, In Patients With Thyroid Eye Disease (TED): Phase 1/2 Clinical Study

por Douglas, Raymond, Ugradar, Shoaib, Cockerham, Kimberley, Eric Turbin, Roger, Tang, Rosa, Nijhawan, Navdeep, O’Shaughnessy, Denis J, Summerfelt, Rochelle M, She, Angela, Katz, Barrett
Publicado 2023